Skip to main navigation Skip to search Skip to main content

Study of oral clofarabine plus low-dose cytarabine in previously treated AML and high-risk MDS patients at least age 60.

  • K. M. Smith
  • , E. Estey
  • , J. M. Pagel

    Research output: Contribution to journal › Article › peer-review

    Original languageAmerican English
    JournalJournal of Clinical Oncology
    Volume29
    DOIs
    StatePublished - May 20 2011

    Disciplines

    • Physical Therapy
    • Medicine and Health Sciences

    Cite this